Shares of AngioDynamics (NASDAQ: ANGO) surged 10.18% in pre-market trading on Tuesday, July 15, 2025, reaching $10.61, up from the previous closing price of $9.63.
The company reported Q4 2025 revenue of $80.16 million, surpassing estimates of $74.26 million by 8% and marking a 12.9% increase from $70.98 million a year ago. AngioDynamics posted an adjusted loss of $0.03 per share, beating the estimated loss of $0.12 and improving from a loss of $0.06 per share in the same quarter last year.
For fiscal year 2026, AngioDynamics forecasts earnings ranging from a loss of $0.35 to earnings of $0.25 per share, compared to the estimated loss of $0.23 per share. Revenue is projected between $305.00 million and $310.00 million, slightly above the estimate of $304.86 million.
